BULLISHWHALES
BullishWhales · Congress · Trade Detail
NYSE: ABBVAbbVie Inc
DemocratHouse

Kathy E. Manning sold AbbVie Inc (NYSE: ABBV)

Kathy E. Manning (D-NC), a U.S. Representative, has disclosed 18 trades in AbbVie Inc (ABBV) since 2021, 10 purchases and 8 sales, worth an estimated $193K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Kathy E. Manning sold $1,001 - $15,000 of AbbVie Inc (NYSE: ABBV) on April 30, 2021. Since that trade, ABBV is up +134.91% against the S&P 500 up +93.52%, an outperformance of +41.39%.

Across these filings, Kathy E. Manning has been a net buyer of ABBV (a buy-to-sell ratio of 1.25). The most recent disclosed ABBV transaction shown was dated July 2, 2024. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABBV trades
18
Disclosed Vol
$193K
Buys
10
56%
Sells
8
44%
Buy / Sell
1.25
ratio
First → Last
2021–2024

Kathy E. Manning's ABBV trades vs the price

ABBV is up +134.91% since Kathy E. Manning sold on April 30, 2021, versus +93.52% for the S&P 500.

Performance since this trade

Price change since trade
+134.91%
S&P 500 change since trade
+93.52%
Outperformance vs S&P 500
+41.39%

All Kathy E. Manning ABBV trades

TradedTypeSizeReturn
July 2, 2024BUY$155.08+40.01%
July 2, 2024BUY$155.08+40.01%
January 23, 2024BUY$155.07+40.02%
January 23, 2024BUY$155.07+40.02%
April 28, 2023SELL$135.70+60.00%
April 28, 2023SELL$135.70+60.00%
September 12, 2022BUY$124.11+74.95%
September 12, 2022BUY$124.11+74.95%
July 27, 2022SELL$131.89+64.63%
July 27, 2022BUY$131.89+64.63%
July 27, 2022SELL$131.89+64.63%
July 27, 2022SELL$131.89+64.63%
July 27, 2022BUY$131.89+64.63%
July 27, 2022SELL$131.89+64.63%
July 15, 2022BUY$134.04+61.99%
July 15, 2022BUY$134.04+61.99%
April 30, 2021SELL$92.43+134.91%
April 30, 2021SELL$92.43+134.91%

Kathy E. Manning & ABBV trading FAQ

Is it legal for Kathy E. Manning to trade AbbVie Inc (ABBV) stock?

Yes. Members of Congress are allowed to trade individual stocks, including AbbVie Inc (ABBV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.

When did Kathy E. Manning sell ABBV?

Kathy E. Manning disclosed a sale of $1,001 - $15,000 of AbbVie Inc (ABBV) on April 30, 2021, according to public STOCK Act filings.

How has ABBV performed since Kathy E. Manning's trade?

Since Kathy E. Manning sold ABBV on April 30, 2021, the stock is up +134.91%, versus +93.52% for the S&P 500 over the same period, an outperformance of +41.39%.

How many times has Kathy E. Manning traded ABBV?

Kathy E. Manning has disclosed 18 ABBV trades since 2021 (10 purchases and 8 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABBV trades?

BullishWhales tracks every disclosed congressional trade in AbbVie Inc (ABBV) on the AbbVie Inc congressional trading page, which aggregates filings across all members of Congress.

Kathy E. Manning's ABBV tradesAll congressional filings for AbbVie IncKathy E. Manning's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.

v1.0.30